Cholesterol metabolism and resistance to tamoxifen. - Archive ouverte HAL Access content directly
Journal Articles Current Opinion in Pharmacology Year : 2012

Cholesterol metabolism and resistance to tamoxifen.

(1) , (2, 3) , (4)
1
2
3
4

Abstract

The oncoprotein MUC-1 was shown to upregulate the transcription of genes encoding cholesterol and lipid metabolic enzymes and correlated with a resistance to Tamoxifen (Tam) despite the presence of estrogen receptor α in breast cancer tumors. The importance of this observation is supported by molecular studies on Tam suggesting two additional pharmacological targets involved in cholesterol metabolism. These observations demonstrate the potential importance of cholesterol and lipid metabolism in the pharmacology/therapeutic effects of Tam.
Not file

Dates and versions

inserm-00743466 , version 1 (19-10-2012)

Identifiers

Cite

Marc Poirot, Sandrine Silvente-Poirot, Ralph R. Weichselbaum. Cholesterol metabolism and resistance to tamoxifen.. Current Opinion in Pharmacology, 2012, 12 (6), pp.683-9. ⟨10.1016/j.coph.2012.09.007⟩. ⟨inserm-00743466⟩
83 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More